Skip to main content
Syed Kazmi, MD, Oncology, Dallas, TX

SyedMohammad AliKazmiMD

Oncology • Dallas, TX

Physician

Join to view full profile

Dr. Kazmi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kazmi's full profile

Already have an account?

  • Office

    5323 Harry Hines Boulevard
    Dallas, TX 75390
    Phone+1 214-645-4673
    Fax+1 214-645-2542

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2007 - 2010
  • Aga Khan Medical College
    Aga Khan Medical CollegeClass of 2004

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2017 - 2026
  • NM State Medical License
    NM State Medical License 2013 - 2019
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • jb1-802 by Jubilant
    jb1-802 by JubilantSeptember 30th, 2021
  • Jubilant Therapeutics Strengthens Board of Directors with Addition of Leila Alland, M.D. And Announces Appointment of Jeremy Barton, M.D., as Strategic Advisor and Interim CMO
    Jubilant Therapeutics Strengthens Board of Directors with Addition of Leila Alland, M.D. And Announces Appointment of Jeremy Barton, M.D., as Strategic Advisor and Interim CMOAugust 16th, 2021
  • Jubilant Therapeutics Announces Appointment of Luca Rastelli, Ph.D. As Chief Scientific Officer
    Jubilant Therapeutics Announces Appointment of Luca Rastelli, Ph.D. As Chief Scientific OfficerMarch 8th, 2021
  • Join now to see all

Dr. Syed Kazmi, Dr. Syed Kazmi, MD, Dr. S Kazmi, Dr. Syed Mohammad Ali Kazmi